12. Characteristics of calcium-phosphorus metabolization disorder and growth retardation in children with end-stage renal disease
Main Article Content
Abstract
Growth retardation is a significant complication in children with chronic kidney disease (CKD) and end-stage chronic kidney disease (ESRD). Children with ESRD have growth retardation due to poor nutrition, anemia, bone and mineral disorders, growth hormone deficiency, and steroid exposure. A descriptive study was conducted on 54 ESRD children undergoing renal replacement therapy (79.6% peritoneal dialysis and 20.4% hemodialysis) at the Vietnam National Children's Hospital (55.6% men). The youngest was 5 months old and the oldest was 16 years old. 81.5% were diagnosed with stunting according to WHO with height for age (HFA) below -2SD. 23 out of 54 children (42.6%) have severe stunting with an HFA below -3SD. The percentages of children with total hypocalcemia and vitamin D deficiency were 68.5% and 48.1%, respectively. 80.9% have hyperphosphatemia and 96.7% have increased PTH.. Increased serum PTH was associated with ESRD children with growth retardation (p < 0.05).
Article Details
Keywords
Growth retardation, ESRD, Calcium, phosphate, PTH
References
2. Furth SL, Hwang W, Yang C, Neu AM, Fivush BA, Powe NR. Growth failure, risk of hospitalization and death for children with end-stage renal disease. Pediatr Nephrol. 2002; 17(6): 450-455. doi:10.1007/s00467-002-0838-x.
3. Salas P, Pinto V, Rodriguez J, Zambrano MJ, Mericq V. Growth Retardation in Children with Kidney Disease. International Journal of Endocrinology. 2013; 2013: e970946. doi:10.1155/2013/970946.
4. Ureña Torres PA, Souberbielle JC, Solal MC. Bone Fragility in Chronic Kidney Disease Stage 3 to 5: The Use of Vitamin D Supplementation. Metabolites. 2022; 12(3): 266. doi:10.3390/metabo12030266.
5. Moe S, Drüeke T, Cunningham J, et al. Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney International. 2006; 69(11): 1945-1953. doi:10.1038/sj.ki.5000414.
6. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney inter, Suppl. 2013; (3): 1-150.
7. Martinez-Millana A, Hulst JM, Boon M, et al. Optimisation of children z-score calculation based on new statistical techniques. PLoS One. 2018; 13(12): e0208362. doi:10.1371/journal.pone.0208362.
8. Munns CF, Shaw N, Kiely M, et al. Global Consensus Recommendations on Prevention and Management of Nutritional Rickets. J Clin Endocrinol Metab. 2016; 101(2): 394-415. doi:10.1210/jc.2015-2175.
9. Menezes FS de, Leite HP, Fernandez J, Benzecry SG, Carvalho WB de. Hypophosphatemia in critically ill children. Rev Hosp Clin. 2004; 59: 306-311. doi:10.1590/S0041-87812004000500015.
10. Goyal R, Jialal I. Hyperphosphatemia. In: StatPearls. StatPearls Publishing; 2023. Accessed April 25, 2023. http://www.ncbi.nlm.nih.gov/books/NBK551586/.
11. Hidayati EL, Trihono PP. Admission characteristics of pediatric chronic kidney disease. Paediatrica Indonesiana. 2011; 51(4): 192-197. doi:10.14238/pi51.4.2011.192-7.
12. Becherucci F, Roperto RM, Materassi M, Romagnani P. Chronic kidney disease in children. Clinical Kidney Journal. 2016; 9(4): 583-591. doi:10.1093/ckj/sfw047.
13. Wesseling K, Bakkaloglu S, Salusky I. Chronic kidney disease mineral and bone disorder in children. Pediatr Nephrol. 2008; 23(2): 195-207. doi:10.1007/s00467-007-0671-3.
14. Luo D, Zhao W, Lin Z, et al. The Effects of Hemodialysis and Peritoneal Dialysis on the Gut Microbiota of End-Stage Renal Disease Patients, and the Relationship Between Gut Microbiota and Patient Prognoses. Front Cell Infect Microbiol. 2021; 11:579386. doi:10.3389/fcimb.2021.579386.
15. Hogg RJ, Furth S, Lemley KV, et al. National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics. 2003; 111(6 Pt 1):1416-1421. doi:10.1542/peds.111.6.1416.